An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model

Ryu Kobayashi, Hiromichi Wakui, Kengo Azushima, Kazushi Uneda, Sona Haku, Kohji Ohki, Kotaro Haruhara, Sho Kinguchi, Miyuki Matsuda, Masato Ohsawa, Yoshiyuki Toya, Akira Nishiyama, Akio Yamashita, Katsuyuki Tanabe, Yohei Maeshima, Satoshi Umemura, Kouichi Tamura

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Angiotensin II type 1 receptor-associated protein (ATRAP) promotes AT1R internalization along with suppression of hyperactivation of tissue AT1R signaling. Here, we provide evidence that renal ATRAP plays a critical role in suppressing hypertension in a mouse remnant kidney model of chronic kidney disease. The effect of 5/6 nephrectomy on endogenous ATRAP expression was examined in the kidney of C57BL/6 and 129/Sv mice. While 129/Sv mice with a remnant kidney showed decreased renal ATRAP expression and developed hypertension, C57BL/6 mice exhibited increased renal ATRAP expression and resistance to progressive hypertension. Consequently, we hypothesized that downregulation of renal ATRAP expression is involved in pathogenesis of hypertension in the remnant kidney model of chronic kidney disease. Interestingly, 5/6 nephrectomy in ATRAP-knockout mice on the hypertension-resistant C57BL/6 background caused hypertension with increased plasma volume. Moreover, in knockout compared to wild-type C57BL/6 mice after 5/6 nephrectomy, renal expression of the epithelial sodium channel α-subunit and tumor necrosis factor-α was significantly enhanced, concomitant with increased plasma membrane angiotensin II type 1 receptor in the kidneys. Thus, renal ATRAP downregulation is involved in the onset and progression of blood pressure elevation caused by renal mass reduction, and implicates ATRAP as a therapeutic target for hypertension in chronic kidney disease.

Original languageEnglish
Pages (from-to)1115-1125
Number of pages11
JournalKidney International
Volume91
Issue number5
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Angiotensin Type 1 Receptor
Chronic Renal Insufficiency
Hypertension
Kidney
Proteins
Nephrectomy
129 Strain Mouse
Inbred C57BL Mouse
Down-Regulation
Epithelial Sodium Channels
Plasma Volume
Knockout Mice
Tumor Necrosis Factor-alpha

Keywords

  • chronic kidney disease
  • hypertension
  • renal tubules
  • renin–angiotensin system

ASJC Scopus subject areas

  • Medicine(all)
  • Nephrology

Cite this

An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model. / Kobayashi, Ryu; Wakui, Hiromichi; Azushima, Kengo; Uneda, Kazushi; Haku, Sona; Ohki, Kohji; Haruhara, Kotaro; Kinguchi, Sho; Matsuda, Miyuki; Ohsawa, Masato; Toya, Yoshiyuki; Nishiyama, Akira; Yamashita, Akio; Tanabe, Katsuyuki; Maeshima, Yohei; Umemura, Satoshi; Tamura, Kouichi.

In: Kidney International, Vol. 91, No. 5, 01.05.2017, p. 1115-1125.

Research output: Contribution to journalArticle

Kobayashi, R, Wakui, H, Azushima, K, Uneda, K, Haku, S, Ohki, K, Haruhara, K, Kinguchi, S, Matsuda, M, Ohsawa, M, Toya, Y, Nishiyama, A, Yamashita, A, Tanabe, K, Maeshima, Y, Umemura, S & Tamura, K 2017, 'An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model', Kidney International, vol. 91, no. 5, pp. 1115-1125. https://doi.org/10.1016/j.kint.2016.10.035
Kobayashi, Ryu ; Wakui, Hiromichi ; Azushima, Kengo ; Uneda, Kazushi ; Haku, Sona ; Ohki, Kohji ; Haruhara, Kotaro ; Kinguchi, Sho ; Matsuda, Miyuki ; Ohsawa, Masato ; Toya, Yoshiyuki ; Nishiyama, Akira ; Yamashita, Akio ; Tanabe, Katsuyuki ; Maeshima, Yohei ; Umemura, Satoshi ; Tamura, Kouichi. / An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model. In: Kidney International. 2017 ; Vol. 91, No. 5. pp. 1115-1125.
@article{68ac6137ed87422880e05424d96e9f09,
title = "An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model",
abstract = "Angiotensin II type 1 receptor-associated protein (ATRAP) promotes AT1R internalization along with suppression of hyperactivation of tissue AT1R signaling. Here, we provide evidence that renal ATRAP plays a critical role in suppressing hypertension in a mouse remnant kidney model of chronic kidney disease. The effect of 5/6 nephrectomy on endogenous ATRAP expression was examined in the kidney of C57BL/6 and 129/Sv mice. While 129/Sv mice with a remnant kidney showed decreased renal ATRAP expression and developed hypertension, C57BL/6 mice exhibited increased renal ATRAP expression and resistance to progressive hypertension. Consequently, we hypothesized that downregulation of renal ATRAP expression is involved in pathogenesis of hypertension in the remnant kidney model of chronic kidney disease. Interestingly, 5/6 nephrectomy in ATRAP-knockout mice on the hypertension-resistant C57BL/6 background caused hypertension with increased plasma volume. Moreover, in knockout compared to wild-type C57BL/6 mice after 5/6 nephrectomy, renal expression of the epithelial sodium channel α-subunit and tumor necrosis factor-α was significantly enhanced, concomitant with increased plasma membrane angiotensin II type 1 receptor in the kidneys. Thus, renal ATRAP downregulation is involved in the onset and progression of blood pressure elevation caused by renal mass reduction, and implicates ATRAP as a therapeutic target for hypertension in chronic kidney disease.",
keywords = "chronic kidney disease, hypertension, renal tubules, renin–angiotensin system",
author = "Ryu Kobayashi and Hiromichi Wakui and Kengo Azushima and Kazushi Uneda and Sona Haku and Kohji Ohki and Kotaro Haruhara and Sho Kinguchi and Miyuki Matsuda and Masato Ohsawa and Yoshiyuki Toya and Akira Nishiyama and Akio Yamashita and Katsuyuki Tanabe and Yohei Maeshima and Satoshi Umemura and Kouichi Tamura",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.kint.2016.10.035",
language = "English",
volume = "91",
pages = "1115--1125",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model

AU - Kobayashi, Ryu

AU - Wakui, Hiromichi

AU - Azushima, Kengo

AU - Uneda, Kazushi

AU - Haku, Sona

AU - Ohki, Kohji

AU - Haruhara, Kotaro

AU - Kinguchi, Sho

AU - Matsuda, Miyuki

AU - Ohsawa, Masato

AU - Toya, Yoshiyuki

AU - Nishiyama, Akira

AU - Yamashita, Akio

AU - Tanabe, Katsuyuki

AU - Maeshima, Yohei

AU - Umemura, Satoshi

AU - Tamura, Kouichi

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Angiotensin II type 1 receptor-associated protein (ATRAP) promotes AT1R internalization along with suppression of hyperactivation of tissue AT1R signaling. Here, we provide evidence that renal ATRAP plays a critical role in suppressing hypertension in a mouse remnant kidney model of chronic kidney disease. The effect of 5/6 nephrectomy on endogenous ATRAP expression was examined in the kidney of C57BL/6 and 129/Sv mice. While 129/Sv mice with a remnant kidney showed decreased renal ATRAP expression and developed hypertension, C57BL/6 mice exhibited increased renal ATRAP expression and resistance to progressive hypertension. Consequently, we hypothesized that downregulation of renal ATRAP expression is involved in pathogenesis of hypertension in the remnant kidney model of chronic kidney disease. Interestingly, 5/6 nephrectomy in ATRAP-knockout mice on the hypertension-resistant C57BL/6 background caused hypertension with increased plasma volume. Moreover, in knockout compared to wild-type C57BL/6 mice after 5/6 nephrectomy, renal expression of the epithelial sodium channel α-subunit and tumor necrosis factor-α was significantly enhanced, concomitant with increased plasma membrane angiotensin II type 1 receptor in the kidneys. Thus, renal ATRAP downregulation is involved in the onset and progression of blood pressure elevation caused by renal mass reduction, and implicates ATRAP as a therapeutic target for hypertension in chronic kidney disease.

AB - Angiotensin II type 1 receptor-associated protein (ATRAP) promotes AT1R internalization along with suppression of hyperactivation of tissue AT1R signaling. Here, we provide evidence that renal ATRAP plays a critical role in suppressing hypertension in a mouse remnant kidney model of chronic kidney disease. The effect of 5/6 nephrectomy on endogenous ATRAP expression was examined in the kidney of C57BL/6 and 129/Sv mice. While 129/Sv mice with a remnant kidney showed decreased renal ATRAP expression and developed hypertension, C57BL/6 mice exhibited increased renal ATRAP expression and resistance to progressive hypertension. Consequently, we hypothesized that downregulation of renal ATRAP expression is involved in pathogenesis of hypertension in the remnant kidney model of chronic kidney disease. Interestingly, 5/6 nephrectomy in ATRAP-knockout mice on the hypertension-resistant C57BL/6 background caused hypertension with increased plasma volume. Moreover, in knockout compared to wild-type C57BL/6 mice after 5/6 nephrectomy, renal expression of the epithelial sodium channel α-subunit and tumor necrosis factor-α was significantly enhanced, concomitant with increased plasma membrane angiotensin II type 1 receptor in the kidneys. Thus, renal ATRAP downregulation is involved in the onset and progression of blood pressure elevation caused by renal mass reduction, and implicates ATRAP as a therapeutic target for hypertension in chronic kidney disease.

KW - chronic kidney disease

KW - hypertension

KW - renal tubules

KW - renin–angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=85009274788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009274788&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2016.10.035

DO - 10.1016/j.kint.2016.10.035

M3 - Article

VL - 91

SP - 1115

EP - 1125

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -